Taiwan biomedical sector to see biggest overseas funding case

Taipei-based Oneness Biotech Co. Ltd. (合一生技) set the price for its global depositary receipt (GDR) issuance on Wednesday that will make it the biggest ever overseas fundraising case by a company in Taiwan's biomedical sector.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)